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Renal stone formation is a common multifactorial disorder, of unknown etiology, with an established genetic
contribution. Lifetime risk for nephrolithiasis is ∼10% in Western populations, and uric acid stones account for
5%–10% of all stones, depending on climatic, dietary, and ethnic differences. We studied a small, isolated founder
population in Sardinia, characterized by an increased prevalence of uric acid stones, and performed a genomewide
search in a deep-rooted pedigree comprising many members who formed uric acid renal stones. The pedigree was
created by tracing common ancestors of affected individuals through a genealogical database based on archival
records kept by the parish church since 1640. This genealogical information was used as the basis for the study
strategy, involving screening for alleles shared among affected individuals, originating from common ancestors, and
utilization of large pedigrees to obtain greater power for linkage detection. We performed multistep linkage and
allele-sharing analyses. In the initial stage, 382 markers were typed in 14 closely related affected subjects; interesting
regions were subsequently investigated in the whole sample. We identified two chromosomal regions that may
harbor loci with susceptibility genes for uric acid stones. The strongest evidence was observed on 10q21-q22, where
a LOD score of 3.07 was obtained for D10S1652 under an affected-only dominant model, and a LOD score of
3.90 was obtained using a dominant pseudomarker assignment. The localization was supported also by multipoint
allele-sharing statistics and by haplotype analysis of familial cases and of unrelated affected subjects collected from
the isolate. In the second region on 20q13.1-13.3, multipoint nonparametric scores yielded suggestive evidence in
a ∼20-cM region, and further analysis is needed to confirm and fine-map this putative locus. Replication studies
are required to investigate the involvement of these regions in the genetic contribution to uric acid stone formation.
Introduction
Nephrolithiasis is a common disease with multifactorial
etiopathogenesis (Jaeger 1996; Baggio 1999). Its prev-
alence inWestern populations is ∼10% (Serio and Fraioli
1999; Rivers et al. 2000), although geographical and
ethnic differences among populations have also been re-
ported (Soucie et al. 1996). The major classes of formed
stones are calcium oxalate, calcium phosphate, uric acid,
struvite, and cystine. The majority of stone formers have
disturbances either in the metabolism and excretion of
stone constituents or in promoters (Siddiqui et al. 1998)
and inhibitors of crystallization (Dussol and Berland
1998).
Clinical and epidemiological studies have docu-
mented that several types of risk factors are involved in
Received December 27, 2000; accepted for publication March 7,
2001; electronically published April 17, 2001.
Address for correspondence and reprints: Dr. Maria Neve Ombra,
Istituto di Genetica Molecolare, CNR, Casella Postale, 07040 Santa
Maria La Palma (SS), Italy. E-mail: ombra@igm.ss.cnr.it
* These authors contributed equally to this work.
 2001 by The American Society of Human Genetics. All rights reserved.
0002-9297/2001/6805-0007$02.00
disease etiology, such as dietary habits, warm climate,
and familial occurrence (Jaeger 1996; Curhan et al.
1997). It is well recognized that nephrolithiasis has a
genetic component (Curhan et al. 1997; Scheinman
1999) and specific genes that cause the cystine lithiasis
have been identified (Pras et al. 1994; Bisceglia et al.
1997) (CSNU [MIM 220100]). Evidence for linkage on
chromosome 12q12-q14 has been reported for idio-
pathic calcium stone formation (Scott et al. 1999) (ox-
alate [MIM 167030]), whereas absorptive hypercalci-
uria, a common cause of kidney stones, has been
mapped to 1q23.3-q24 (Reed 1999) (hypercalciuria
[MIM 143870]). However, genes that predispose to the
most common forms of kidney stones remain unknown,
and, therefore, important genetic factors involved in dis-
ease etiology remain to be identified.
Gene mapping for complex traits is a major challenge
of current research studies, since it is hampered by sev-
eral factors, such as genetic heterogeneity, small effects
of disease alleles on risks, and confounding effects
caused by gene-environment and gene-gene interactions.
Numerous susceptibility genes are likely to be involved
in common diseases such as nephrolithiasis, and most
of these genes may be common in populations, sug-
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gesting interactions of different allelic variants in disease
etiology. Selection of homogeneous study populations
with reduced genetic variability and etiological heter-
ogeneity is therefore important to increasing the pos-
sibility of identification of susceptibility genes. Isolated
populations have been successfully utilized in mapping
Mendelian genes and are likely to be particularly useful
for mapping predisposing genes for common, complex
diseases (Terwilliger and Weiss 1998; Kruglyak 1999;
Wright et al. 1999; Peltonen et al. 2000). A small num-
ber of founding individuals and a high rate of past and
present consanguineous and endogamous marriages—
typical of small communities—reduce the number of
susceptibility genes in the population, increasing genetic
homogeneity. Furthermore, since individuals are ex-
posed to a common environment and a relatively uni-
form lifestyle, nongenetic variability is also minimized,
and the noise caused by other etiological determinants
is therefore reduced. All these characteristics facilitate
the search for susceptibility genes involved in complex
disease etiology.
We studied an isolated Sardinian village where ne-
phrolithiasis prevalence is higher than in the general
Western population. We conducted a multistep ge-
nomewide search (GWS) in a deep-rooted pedigree orig-
inating from the village and comprising 37 relatedmem-
bers affected by uric acid renal stones (UAS). Selecting
families with multiple affected individuals originating
from populations with restricted genetic variation may
result in enrichment of shared genetic determinants and
may increase the power of the study. Our study strategy
was based on the search for genomic segments shared
identical-by-descent (IBD) by affected individuals orig-
inating from common ancestors (Houwen et al. 1994;
Nikali et al. 1995; Hovatta et al. 1999). GWS was util-
ized to identify loci underlying this common disorder
and to search for major genetic determinants in this
population. We identified a chromosomal region on
10q21-q22 that might harbor a susceptibility gene for
UAS. Suggestive evidence for linkage to the 20q13.1-
q13.3 region was also obtained in our study.
Subjects and Methods
Population and Genealogical Data
We identified an isolated village, Talana, in central
Sardinia, with 1,200 inhabitants, that is characterized
by slow population growth, high endogamy, and high
inbreeding (Wright et al. 1999). Characterization of ma-
ternal and paternal lines through mitochondrial DNA
and Y-chromosome microsatellite markers allowed us to
establish that the majority of the population of present-
day Talana descends from !20 founder individuals (au-
thors’ unpublished data).
The limited number of founders and isolation in-
creased genetic homogeneity, as compared with that in
other larger, more exogamous populations. Geographi-
cal and cultural isolation have generated a great deal of
homogeneity in lifestyle and eating habits, providing an
ideal uniform context for studies of complex diseases.
Precise details of births, deaths, marriages, and people’s
origins have been preserved since 1640 in the parochial
Quinque Libri and in the municipal archives. All data
were transcribed on paper forms and then were trans-
ferred into appropriate databases, allowing the creation
of genealogical trees for almost any individual.
Subjects
All individuals participating in the study gave in-
formed consent, and all samples were taken according
to the Helsinki declaration. Subjects enrolled in this
study were examined by the same physicians and were
subjected to standardized interviews. Individuals with a
history of urinary tract infection or with any secondary
condition that might predispose to kidney stones (e.g.,
inflammatory bowel disease or gout) were not included.
All subjects affected by renal stones and their family
members underwent renal ultrasound examination to
identify asymptomatic cases and to confirm previous di-
agnoses. Ultrasonography is used to image calculi, such
as UAS, that are nonopaque on X-rays (Pollack et al.
1978). Uric acid nephrolithiasis is revealed by the pres-
ence of a radiolucent stone and urine acidity (pH !
), (Pak et al. 1980; Stojimirovic 1998). Clinical tests5.5
included crystallographic analysis of stones; 24-h uri-
nalysis of oxalates, citrates, NH4, PO4, uric acid,
calcium, and acidity titration; and serum concentration
of calcium, uric acid, urea, creatinine, sodium, and phos-
phates (Pak et al. 1980; Dawson and Whitfield 1996).
Several dietary factors have been related to stone for-
mation, on the basis of per capita consumption, through
epidemiological studies. Dietary calcium, animal pro-
teins, oxalate, and sodium increase the likelihood of
stone formation, whereas fiber, magnesium, and potas-
sium seem to reduce the risk (Hassapidou et al. 1999).
We collected data on dietary habits for a representative
sample of the population of Talana, comprising 40 un-
affected unrelated subjects and 60 patients with renal
stones. All subjects completed a questionnaire regarding
amount, type, and frequency of food intake. The ques-
tionnaire was analogous to the analytical tool used by
Hassapidou et al. (1999), adapted to include the most
common foods of the Mediterranean diet.
Unaffected individuals were checked by ultrasonog-
raphy to ensure that they did not carry any UAS. The
mean age at observation of unaffected controls (∼63
years) was sufficiently high to have given an elevated
probability of developing stones, since we observed a
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low age at onset in affected subjects (mean age at onset
∼38 years). Familial relationships among subjects were
verified by searches of the genealogical database of our
largely inbred study population. No controls had a
closer degree of relatedness than second cousins: 2 of
40 controls were second cousins, 13 were third cousins,
4 were third cousins once removed, and 9 were fourth
cousins. The remaining controls were more distant than
fourth cousins once removed.
Through the archival database common ancestors
were identified for 37 of 60 affected individuals. They
are linked in an extended 10-generation pedigree com-
prising 156 subjects (fig. 1), founded by a single ancestral
couple born at the beginning of the 18th century. Among
the remaining affected subjects, 15 were used in the as-
sociation study (see Statistical Analysis section), since
they constituted an independent sample of unrelated
cases and were not connected either to the control sub-
ject (i.e., more distant than fourth cousins), or to the
familial case subjects.
Genotyping
Genomic DNA was extracted from 10 ml EDTA-
treated blood, as described by Miller et al. (1988). PCR
reactions were loaded on an ABI Prism 377 DNA An-
alyzer (PE Biosystems), using denaturating 5.0% poly-
acrylamide gels. The genotyping data were processed by
GENESCAN version 3.1 and GENOTYPER version 2.5
software.
Multistep GWS
Stage I.—The GWS initially was performed on a re-
duced sample of 17 individuals from a large six-gener-
ation pedigree that included 14 members (6 men and 8
women) affected by UAS. The family members analyzed
in stage I are highlighted in figure 1. We used the 382
microsatellite-marker mapping set from ABI Prism, ver-
sion 2. Markers are uniformly distributed over the ge-
nome at an average distance of ∼10 cM. Genetic maps
were derived from Ge´ne´thon (Dib et al. 1996), and allele
frequencies for the population of Talana were estimated
from an additional sample of 25 unrelated individuals.
The family was analyzed using parametric linkage and
nonparametric IBD-sharing approaches. Regions yield-
ing suggestive evidence of linkage (LOD score 11) and/
or excess IBD sharing among affected members (P !
) were followed up in the second stage..05
Stage II.—Interesting regions identified in stage I were
investigated in more-distantly related affected individ-
uals selected from the large pedigree. Eleven regions on
10 chromosomes were followed up, through linkage and
IBD-sharing analysis, in the large pedigree shown in fig-
ure 1. The pedigree was divided into branches for anal-
ysis, so that no meiosis was represented in more than
one subfamily: descendants of individuals III:5–III:6, de-
scendants of individuals IV:3–IV:4, and descendants of
individuals IV:1–IV:2 (breaking the loops at individuals
VII:6 and VII:1 for the two latter pedigrees) (fig. 1). The
subdivision was necessary for the computational require-
ments of linkage analysis, which is not feasible in such
a large family. We consider a powerful strategy to use
all the information on genealogical data of our study
sample, and examination of smaller subfamilies there-
fore was not attempted at this stage of the analysis.
Stage III.—Linkage and IBD analyses were performed
with a denser set of markers in the regions that showed
evidence of linkage and/or excess IBD sharing in the
extended pedigree. A two-point dominant pseudomar-
ker approach was also performed for markers lying in
the identified regions. Six markers spanning the 10q21-
q22 region were typed in the entire family sample:
D10S1640, D10S1719, and D10S1670 were selected
from the Ge´ne´thon database, and D10S609, D10S1715,
and D10S1241 were chosen from the GenomeDatabase.
In the 20q13.1-q13.3 region, the following additional
markers were chosen: D20S888, D20S902, and
D20S102 from the Ge´ne´thon database and D20S840,
D20S52, D20S746, D20S149, D20S158, D20S459, and
AFMa202yb9 from the Genome Database. Marker or-
der was derived from the physical map of the Sanger
Centre, and genetic distances were derived from the Ge-
netic Location Database or were inferred from physical
distances. In order to compare the frequency of specific
alleles and haplotypes between case and control subjects,
15 affected and 40 unaffected unrelated subjects, de-
scribed in the Subjects section, were genotyped at mark-
ers lying in the regions that provided significant linkage
results.
Statistical Analysis
Mendelian inconsistencies were checked with the
PEDMANAGER program, version 0.9. The program
was also used to calculate allele frequencies for each
marker from the additional sample of 25 unrelated in-
dividuals selected from the general population.
Two-point LOD scores were calculated with FAST-
LINK version 4.1P (Cottingham et al. 1993; Scha¨ffer et
al. 1994) in an affected-only strategy, assuming all non-
affected individuals as phenotypically unknown, since
unaffected subjects do not provide reliable information
on the underlying disease-locus genotype for a complex
disease. Model-based linkage analysis was performed
under both dominant and recessive models assuming dis-
ease-allele frequencies of .01 for the dominant model
and .1 for the recessive model. It has been shown that,
when the true mode of inheritance is unknown, model-
based linkage analysis can still be a robust approach
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Table 1
Anthropometric Characteristics and Food Consumption (Number of Servings per Week of Foods) among Affected and Unaffected





















Affected ( )np 40 62.7517.42b 1.57.09 65.4317.36 26.584.02 11.252.38b 4.101.48b .70.65 10.503.50 11.033.45 3.082.29
Unaffected ( )np 60 54.7518.70 1.56.09 65.4812.37 27.024.90 12.271.87 3.46 .84 .81.57 10.803.71 10.402.80 2.241.19
a Sum of servings/week.
b (statistical significance between mean differences was tested by t-test)..01 ! P ! .05
Even though the choice of genetic model is arbitrary and,
presumably, incorrect, LOD-score models can still out-
perform nonparametric methods (Hodge et al. 1997;
Greenberg et al. 1998; Durner et al. 1999). A pseudo-
marker analysis that was shown to have properties
equivalent to those of an affected-relative IBD-approach
(Trembath et al. 1997; Terwilliger 1998; Go¨ring and
Terwilliger 2000) was also performed in stage III. Under
this approach, every meiosis was made informative for
linkage at the disease locus and affected individuals were
analyzed as if all possible disease genes were shared IBD.
We used a dominant pseudomarker assignment, as de-
scribed by Go¨ring and Terwilliger (2000).
For multipoint analysis we used a model-free ap-
proach based on evaluation of IBD allele sharing among
affected individuals. Multipoint IBD-sharing analysis is
usually restricted to pedigrees of moderate size and struc-
ture. For large pedigrees, like the one we generated, exact
methods are not feasible because of the size and com-
plexity of relationships between affected pairs resulting
in an enormous number of underlying configurations
that are consistent with the observed data. Currentmeth-
ods of analysis for extended and complex pedigrees are
based on Markov chain–Monte Carlo (MCMC) sam-
pling. In our study, multipoint nonparametric statistics
for allele sharing among affected individuals were eval-
uated with SIMWALK2 (Sobel and Lange 1996), a sta-
tistical-genetics program that uses MCMC and simu-
lated annealing algorithms to analyze pedigree data of
any size. The program estimates several IBD-sharing sta-
tistics at each position of the map by sampling IBD con-
figurations (consistent with the data) proportionally to
their likelihoods. SIMWALK2 reports five different sta-
tistics and, in particular, calculates a nonparametric link-
age score (NPL) as implemented in GENEHUNTER
(Kruglyak et al. 1996). The identified region on 10q21-
q22 was also investigated, through exact IBD-sharing
statistics, using the computer program ALLEGRO (Gu-
dbjartsson et al. 2000), although, because of computa-
tional requirements, the large pedigree was split into five
smaller families for the analysis.
Results
Nutritional and Clinical Data
Data on body weight, height, body-mass index (BMI),
age, and food consumption have been collected and sum-
marized in table 1. The results of the survey evidenced
no major differences of dietary habits among cases and
controls in terms of quality of food associated with in-
creased or decreased likelihood of renal-stone formation.
Intake of animal proteins frommeat, a known risk factor
for nephrolithiasis, was actually slightly higher in con-
trols than in affected subjects. It should also be empha-
sized that most of the population of Talana residents
lead a rather uniform and conservative lifestyle, which
includes traditional and rural dietary habits. No signif-
icant differences in body weight, height, and BMI mean
values were observed in the two groups.
We identified several subjects in Talana who had renal
stones that showed uric acid as the principal component.
UAS account generally for 5%–10% of all renal stones,
whereas, in our isolate, they were five times more fre-
quent than expected. The risk for UAS formation cor-
relates with the degree of uric acid concentration in urine
and low urinary pH (pH !5.5) (Helabe and Sperling
1994; Asplin 1996). The analysis performed in the sam-
ple of stone formers evidenced that 85% of the inves-
tigated cases had low urinary pH levels (ranging from
5.2 to 5.6), and that acidity titration on 24-h urine was
also higher than normal values in 80% of cases (titration
140 mEq/24 h). Excretion parameters on 24-h urine
showed that 35% of the cases had also high values of
uricosuria (1700 mg/24 h).
Simulation Study
Exact power estimation and assessment of genome-
wide significance through simulation is impractical for
the whole pedigree, given the complexity of the genea-
logical structure, the large number of individuals, and
the unknown mode of disease inheritance. In any case,
a simulation study was performed for the 17-member
pedigree used in stage I, to estimate its power and to
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Table 2










1 D1S2841–D1S207 102.0–110.0 D1S207 .0413 1.40
2 D2S117–D2S126 198.3–226.0 D2S325 NS 1.76
3 D3S1263–D3S1300 27.1–70.1 D3S1289 .0043 1.04
5 D5S2115–D5S408 144.9–202.7 D5S436 .0030
7 D7S516–D7S502 38.5–81.2 D7S484 .0297
10 D10S1652–D10S537 81.9–90.3 D10S537 .0037 1.86 1.50
D10S1651–D10S212 167.7–170.1 D10S212 .0050 1.43
14 D14S261–D14S288 .0–33.2 D14S261 .0292
15 D15S128–D15S1007 .0–22.0 D15S1002 .0099
16 D16S423–D16S3068 .0–41.6 D16S3075 .0065
20 D20S196–D20S171 76.3–101.3 D20S173 .0016 1.80 1.39
a Nonparametric linkage score obtainedwith SIMWALK2 (Statistic E), whichmeasures the degree
of clustering of the marker alleles descending from pedigree founders, for affected individuals only
(Sobel and Lange 1996). Statistic E is analogous to the NPL score as implemented in the GENE-
HUNTER program (Kruglyak et al. 1996). Statistic E indicates whether there are a few descent
trees that are overly represented among the alleles of affected individuals. NS p not significant
( ).P 1 .05
b Two-point LOD score derived using dominant model.
c Two-point LOD score derived using recessive model.
evaluate the type I–error rate of specific cutoff values of
the LOD scores for following-up regions. The program
SLINK (Weeks et al. 1990) was used to generate 200
replicates of the family assuming both linkage (vp
) and nonlinkage. Maximum LOD scores of 2.08 and.05
of 3.24 were obtained under the assumption of linkage
under the dominant and the recessive models, respec-
tively, with ∼50% power. A LOD score 1.0 was ob-
served in 2.6% of the replicates obtained under no link-
age, and this LOD score threshold was used for selecting
regions to follow up in the second stage.
Stage I.—Results from stage I are shown in table 2.
Eleven regions on 10 chromosomes resulted in two-point
LOD scores 11 and/or in P values !.05 for themultipoint
NPL statistic of SIMWALK2. The best results were ob-
served on chromosomes 10 and 20, where both domi-
nant and recessive models provided LOD scores 11 and
the NPL score yielded (peak at markerP ! .005
D10S537, ; peak at marker D20S173,Pp .0037 Pp
, respectively). The 11 regions were further eval-.0016
uated in the second stage. Because our initial GWS was
based on a small sample of individuals belonging to a
single large family, and given the high level of inbreeding
present in the population, we expected to observe a high
rate of false-positive regions caused by both chance shar-
ing among individuals and small sample size. Evaluation
of the identified regions in additional family members
collected from the isolate would allow us to confirm or
exclude the involvement of these regions in the second
stage of the analysis.
Stage II.—When we extended the analysis to the whole
family, we found evidence of linkage and excess IBD
sharing for the chromosome 10 and 20 regions identified
in stage I. On chromosome 10, LOD scores of 3.07 and
2.17 at recombination fraction (v) 0 were observed at
markers D10S1652 and D10S537 (∼5.4 cM apart), re-
spectively, under the affected-only dominant model. Ex-
cess IBD sharing (NPL score: ) was also observedP ! .05
in the region among affected individuals. For chromo-
some 20, a suggestive NPL score ( ) was obtainedP ! .05
between D20S196 and D20S173 (∼16 cM apart). On
chromosome 15, a LOD score of 1.58 was observed at
D15S165, but no significant results were obtained with
the multipoint allele-sharing approach, and the region
was not investigated further. All the remaining regions
identified in GWS stage I resulted in two-point LOD
score !1 and nonsignificant ( ) IBD-sharing sta-P 1 .05
tistics (data not shown).
Stage III.—Six markers spanning the 10.7-cM region
on chromosome 10 and ten markers spanning the 26-
cM region on chromosome 20 were genotyped in this
stage of the analysis. For the chromosome 20 region, a
peak LOD score of 1.09 was obtained at marker
D20S902, whereas suggestive NPL scores ( ) wereP ! .05
observed over an ∼20-cM region between markers
D20S888 and D20S158, with a peak at marker
D20S902 ( ). SIMWALK2 statistic B, whichPp .008
measures the maximum number of alleles among af-
fected individuals descended from any common founder,
was the most significant and reached a peak at marker
D20S902 ( ).Pp .0025
For the chromosome 10 region, results are shown in
table 3. No additional marker gave a better result than
D10S1652, for which a LOD score of 3.90 was obtained
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Table 3
Results of GWS Stage III in Chromosome Region 10q21-q22
cM MARKER HETEROZYGOSITYb








0 D10S1640 .57 1.15 (.0) .43 (.0) .22 (.23) .0069 .0361
2.0 D10S1652 .54 3.07 (.0) .90 (.0) 3.90 (.0) .0058 .0415
2.5 D10S1719 .75 .43 (.18) .66 (.04) .37 (.23) .0054 .0485
5.9 D10S1670 .67 .83 (.11) 1.67 (.0) .74 (.14) .0048 .0495
6.4 D10S1715 .55 .28 (.08) .19 (.05) .31 (.14) .0048 .0463
6.9 D10S1241 .65 .00 (.5) .13 (.18) .00 (.5) .0050 .0545
7.4 D10S537 .76 2.17 (.0) 1.76 (.0) 2.15 (.05) .0077 .0265
10.7 D10S609 .67 .00 (.5) .00 (.5) .00 (.5) .0057 .0329
a No correction for multiple testing due to the different genetic models used was applied.
b Marker heterozygosity estimated from genotyped pedigree members.
c Gene frequency .qp .01
d Gene frequency .qp .1
e Exact P values associated with the S-all scoring function.
by the pseudomarker approach. NPL scores estimated
with SIMWALK2 yielded P values !.05 in the whole
region. Exact NPL scores evaluated with ALLEGRO
(assuming the S-all scoring function and the exponential
model) resulted in P values !.01 in the whole region,
with peaks at markers D10S1670 and D10S1715
( ).Pp .0048
To investigate the significance of the linkage result,
we performed a randomization of the phenotypes in the
family members, simulating a disease gene unlinked to
the marker for which the best evidence of linkage was
obtained (marker D10S1652) and using, in each repli-
cate, true genotypes at marker D10S1652 for available
family members. We used SLINK to generate 500 rep-
licates and MSIM to estimate the probability of observ-
ing by chance a LOD score exceeding the true LOD
score. We observed that, in 3 of 500 replicates, a LOD
score 13.07 was obtained in the affected-only approach,
yielding an associated P value of .006, with an upper
endpoint of the 95% confidence interval of 0.0174 (Ott
1999).
Haplotype inspection in familial cases revealed a com-
mon ∼7.4-cM haplotype (extending from marker
D10S1640 to marker D10S537) in many affected mem-
bers. Portions of this extended haplotype were shared
by most affected members belonging to the family, as
shown in table 4. For marker D10S1652, 19 affected
individuals were homozygous for allele 13 (51.4%) ver-
sus 8 unaffected members (24.2%).
The same 10q region, spanning from D10S1640 to
D10S537, was investigated in 15 unrelated cases and 40
unaffected controls whose haplotypes were recon-
structed from typing of close relatives. A 6.9-cM hap-
lotype between markers D10S1640 andD10S1241 (hap-
lotype 4-13-2-1-3-5), already identified in the family
members, was also the most common extended haplo-
type observed in unrelated cases collected from the gen-
eral population (table 4) and was present in seven af-
fected haplotypes (23.3%), compared with seven control
haplotypes (8.8%). Parts of this haplotype were also
more prevalent in affected chromosomes than in control
chromosomes: haplotype 4-13, for markers D10S1640–
D10S1652, was present in 14 of 30 case haplotypes and
in 19 of 80 control haplotypes ( by two-tailedPp .0340
Fisher’s exact test); haplotype 13-2, for markers
D10S1652–D10S1719, was present in 11 case haplo-
types and in 13 control haplotypes ( by two-Pp .0359
tailed Fisher’s exact test). The allele 13 at marker
D10S1652 was present in 22 affected haplotypes com-
pared with 30 control haplotypes ( , by two-Pp .0011
tailed Fisher’s exact test).
Discussion
We studied a large pedigree comprisingmany individuals
affected by UAS, to identify susceptibility genes under-
lying this complex disease. The genetic contribution to
common forms of nephrolithiasis is well established but
poorly understood, as the number of genes involved in
disease etiology and the magnitude of their effects are
still unknown.
Clinical and epidemiological studies have docu-
mented that several types of risk factors are involved in
disease etiology. Diet, in particular, plays a significant
role in disease etiology. Dietary intake was assessed in
a representative sample of the population of Talana by
a food-frequency questionnaire that was submitted to
unaffected and affected subjects. The results of the sur-
vey show no major differences between unaffected and
affected subjects in terms of quality of food associated
with kidney-stone formation.
Kidney stones may form when concentration of uri-
Table 4
Haplotype Analysis in the 10q21-q22 Region in Affected Family Members and in Unrelated Case Subjects
SUBJECT
MARKER (DISTANCE IN CM)
D10S1640 (0) D10S1652 (2.0) D10S1719 (2.5) D10S1670 (5.9) D10S1715 (6.4) D10S1241 (6.9) D10S537 (7.4)
Affected family members:
IX:27a 2 13 2 1 2 1 7
IX:24 3 13 2 1 2 3 4
VIII:29 3 13 2 1 2 3 8
VIII:18 4 13 2 1 3 5 10
IX:12a 4 13 2 1 3 5 10
VIII:14 4 13 2 1 3 5 10
VIII:16 4 13 2 1 3 5 10
X:4a 4 13 2 1 3 5 10
X:4a 4 13 2 1 3 5 10
VIII:24 4 13 2 1 3 5 10
VIII:23 4 13 2 1 3 5 10
X:5a 4 13 2 1 3 5 10
VIII:25 4 13 2 1 3 5 10
IX:17 4 13 2 1 3 5 10
X:3 4 13 2 1 3 5 10
IX:14a 4 13 2 1 2 5 10
X:5a 4 13 2 3 3 9 8
IX:1a 4 13 3 4 3 1 8
IX:2a 4 13 3 4 3 1 8
VIII:4 4 13 3 1 5 1 4
IX:6a 4 13 4 1 3 5 8
IX:7a 4 13 4 1 3 5 8
X:2 4 13 4 1 3 5 8
VIII:3a 4 13 4 3 3 5 4
IX:12a 4 13 7 3 3 9 4
IX:13 4 13 7 3 3 9 4
IX:27a 4 13 8 1 3 5 7
IX:5 4 13 8 4 3 1 4
IX:6a 4 13 8 4 3 1 4
IX:7a 4 13 8 4 3 1 4
IX:1a 4 13 8 9 3 5 5
IX:2a 4 13 8 9 3 5 5
VIII:9 4 13 8 4 3 1 4
X:1 4 13 8 4 3 1 4
VIII:8 4 13 8 4 3 1 4
VIII:3a 4 13 8 3 3 5 8
IX:14a 4 13 8 3 3 9 8
Unrelated case subjects:
PT1a 2 13 2 1 3 1 8
PT2a 2 13 2 1 2 1 4
PT4 2 13 2 1 2 1 9
PT5 4 13 2 1 3 1 8
PT6 4 13 2 1 3 5 9
PT1a 4 13 2 1 3 5 8
PT7 4 13 2 1 3 5 8
PT8 4 13 2 1 3 5 4
PT3a 4 13 2 1 3 5 4
PT9 4 13 2 1 3 5 10
PT2a 4 13 2 1 3 5 4
PT10 4 13 3 1 3 1 10
PT11 4 13 3 3 3 1 4
PT12 4 13 4 1 3 1 4
PT3a 4 13 4 1 3 5 8
PT13 4 13 8 3 3 5 8
PT14 4 13 8 4 3 5 8
NOTE.—Boxed haplotypes indicate the haplotype shared by affected family members (see text). Among unrelated cases, 7 patients of 15 shared the 4-13-2-1-3-
5 haplotype found in the family. The same haplotype was found only in seven control haplotypes (8.8%) (not shown).
a For these subjects, both haplotypes are shown.
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nary constituents exceeds their solubility. Although hy-
peruricosuria is a risk factor in only 30% of cases, a
common denominator in normo- and hyperuricosuric
patients is a low urinary pH (Smith 1998). Uric acid
solubility decreases abruptly at urinary pH !5.5. Thus,
a long period of urine acidity leads to UAS formation.
It must be considered that a proportion of healthy peo-
ple generally exhibit low urinary pH values and the
same uricuria as some UAS formers. Consequently, even
if low PH is likely to be a necessary determinant for
UAS, it is not a sufficient factor (Koka et al. 2000). Very
little is known about uric acid crystallization inhibitors.
Urinary glycoproteins similar to mucine inhibit uric acid
crystallization (Grases et al. 1999), although genes en-
coding these proteins have not yet been identified.
In a exploratory study performed on our case sub-
jects, we observed low urinary pH levels (mean pH
5.55), and these were the only abnormal values iden-
tified, suggesting that reduced urinary pH could be an
important risk factor for UAS formation in our patients,
although further evaluation is needed to confirm this
hypothesis in a more exhaustive population sample.
For acidification of urine, several processes are re-
sponsible. One mechanism is NH3 production from glu-
tamine, which takes place in the proximal tubule
(Hamm 1987; Hayashi 1998). A reduced NH3 produc-
tion resulting in a decreased buffer capacity for H ions
(caused by lack of glutamine or by an enzymatic defect)
is considered a potential mechanism for permanently
low urinary pH in UAS formers. Nevertheless, we did
not observe a significantly reduced NH3 level among
our cases. Uric acid is the end product of purine deg-
radation in humans, and the kidney plays a predomi-
nant role in its elimination. The molecular basis for
renal urate transport, however, has not been completely
defined.
We performed a GWS, using both parametric and
nonparametric linkage approaches to identify suscep-
tibility genes for UAS, on an extended family comprising
many affected individuals. The family was collected
from a small, isolated Sardinian village, characterized
by genetic and environmental homogeneity. Although
parametric linkage analysis can be problematic for com-
plex traits, the approach can also be especially powerful
when affected individuals arise from genetically isolated
populations and when common ancestors can be iden-
tified (Houwen et al. 1994; Nikali et al. 1995; Hovatta
et al.1999). A two-point LOD score analysis was also
performed between a pseudomarker locus that repre-
sents the maximum possible IBD sharing at the suscep-
tibility locus among affected members and marker loci.
The method was shown to approximate nonparametric
affected-relative approaches (Go¨ring and Terwilliger
2000). Nonparametric methods, based on IBD sharing
among affected relatives, are more commonly used in
the genetic analysis of complex traits, using sib pairs or
general pedigrees of moderate size. In our study, we used
an approximation method for multipoint allele-sharing
analysis based on MCMC that was implemented in the
computer program SIMWALK2 (Sobel and Lange 1996)
and that allowed us to make full use of our family
material. Large pedigrees that include distantly affected
relatives provide greater power for linkage detection,
since the prior probability of sharing any genome seg-
ment is small for distant relatives and evidence of IBD
sharing indicates the presence of a genetic factor con-
tributing to the trait. Furthermore, large pedigrees with
many affected relatives may insure an increased genetic
homogeneity of the trait and, therefore, a more pow-
erful analysis. The study of large families collected from
a genetic isolate can be powerful even for common al-
lelic variants that are likely to have the same ancestral
origin.
A multiple-stage strategy was used in our study. In
the first stage, a subpedigree was genotyped and ana-
lyzed using a relatively sparse map of markers. Regions
with evidence of linkage were followed up in the entire
pedigree increasing marker density. We identify a chro-
mosomal region on 10q21-q22, where LOD scores of
3.07 and 3.90 at were obtained for markervp 0
D10S1652 under dominant-model and pseudomarker
approaches, respectively. Multipoint IBD-sharing anal-
ysis with SIMWALK2 yielded suggestive evidence (P !
) with the NPL statistic, and exact methods resulted.05
in P values !.01 for all markers spanning the 10.7-cM
region. The localization of a new candidate locus on
chromosome 10 is supported by haplotype sharing ob-
served in affected pedigree members, since it is ex-
tremely unlikely that distantly related affected subjects
would share long chromosomal intervals just by chance.
Therefore, this result would indicate IBD sharing of
marker haplotypes surrounding a disease gene, although
it is difficult to evaluate the exact significance of hap-
lotype sharing observed in the family, given the back-
ground inbreeding present in the population.
In small, founder populations, like the one we stud-
ied, linkage disequilibrium may extend over relatively
large intervals (Terwilliger et al. 1998) and therefore
might be detectable in the proximity of a disease gene.
A large proportion of affected individuals are likely to
have inherited the same predisposing genes from com-
mon ancestors and to share IBD portions of chromo-
somal regions around susceptibility genes. The same∼7-
cM haplotype observed in several cases of the large
family reported here was also present at higher fre-
quency among unrelated affected subjects than in un-
affected controls collected from the population. Signif-
icant association was observed with haplotype 4-13 at
markers D10S1640–D10S1652 ( ) and hap-Pp .0340
lotype 13-2 at markers D10S1652–D10S1719 (Pp
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). Stronger association ( ) was observed.0359 Pp .0011
with allele 13 at marker D10S1652, which provided the
highest LOD score in the linkage analysis. Further eval-
uations, using a more exhaustive sample and combining
linkage and association approaches, are needed to con-
firm these preliminary results.
In this study, we also obtained suggestive evidence of
linkage in the 20q13.1-q13.3 region, where excess IBD
sharing among affected subjects was observed over a
large 20-cM region and a peak LOD score of 1.09 was
obtained at marker D20S902.
Analysis of a large pedigree allowed us to include all
known connections among individuals and thus to con-
trol, as much as possible, “hidden” inbreeding that
might inflate the LOD score, creating false-positive
regions (Miano et al. 2000). Deviation from Hardy-
Weinberg equilibrium was also tested in the control
sample and provided no significant results (data not
shown).
Because the first stage of the study was performed in
a reduced sample of affected individuals belonging to a
single large family, our approach was only suitable for
detection of major genes that confer a relatively high
disease risk in the population. However, it might not
have had enough power to detect weak-effect disease
genes, which are likely to be missed when a small sample
of individuals is investigated through GWS. We are
currently extending our study to include more affected
subjects and unaffected control subjects, to confirm the
involvement of the identified region in genetic predis-
position to UAS formation through linkage disequilib-
rium analysis using a denser set of markers.
Analysis of the genes located in this region, based on
the most recent chromosome 10 map, did not reveal
obvious candidates. The lack of a known gene at these
chromosomal regions leads to the possibility that the
identified candidate region might harbor a new suscep-
tibility gene involved in kidney stone formation.
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